- Home
- ISPR vs TSVT Comparison
ISPR vs TSVT Comparison
Compare ISPR & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- TSVT
- Stock Information
- Founded
- ISPR 2019
- TSVT 2021
- Country
- ISPR United States
- TSVT United States
- Employees
- ISPR N/A
- TSVT N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- ISPR Health Care
- TSVT Health Care
- Exchange
- ISPR Nasdaq
- TSVT Nasdaq
- Market Cap
- ISPR 170.1M
- TSVT 258.9M
- IPO Year
- ISPR 2023
- TSVT N/A
- Fundamental
- Price
- ISPR $2.90
- TSVT $5.00
- Analyst Decision
- ISPR Strong Buy
- TSVT Buy
- Analyst Count
- ISPR 2
- TSVT 4
- Target Price
- ISPR $10.75
- TSVT $6.50
- AVG Volume (30 Days)
- ISPR 37.3K
- TSVT 756.8K
- Earning Date
- ISPR 05-16-2025
- TSVT 05-07-2025
- Dividend Yield
- ISPR N/A
- TSVT N/A
- EPS Growth
- ISPR N/A
- TSVT N/A
- EPS
- ISPR N/A
- TSVT N/A
- Revenue
- ISPR $148,524,656.00
- TSVT $48,365,000.00
- Revenue This Year
- ISPR $6.22
- TSVT $84.48
- Revenue Next Year
- ISPR $36.16
- TSVT $9.69
- P/E Ratio
- ISPR N/A
- TSVT N/A
- Revenue Growth
- ISPR 5.10
- TSVT N/A
- 52 Week Low
- ISPR $2.50
- TSVT $2.29
- 52 Week High
- ISPR $8.40
- TSVT $5.30
- Technical
- Relative Strength Index (RSI)
- ISPR 44.55
- TSVT 73.85
- Support Level
- ISPR $2.70
- TSVT $4.97
- Resistance Level
- ISPR $3.00
- TSVT $4.99
- Average True Range (ATR)
- ISPR 0.24
- TSVT 0.02
- MACD
- ISPR 0.02
- TSVT -0.04
- Stochastic Oscillator
- ISPR 31.45
- TSVT 75.00
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.